Belluscura plc (AIM: BELL)
London
· Delayed Price · Currency is GBP · Price in GBX9.50
-0.50 (-5.00%)
Nov 21, 2024, 10:20 AM GMT+1
Belluscura Company Description
Belluscura plc develops and commercialize oxygen related medical device products in the United States.
The company offers X-PLOR and DISCOV-R, a modular portable oxygen concentrator; and related accessories.
Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
Belluscura plc
| Country | United Kingdom |
| Founded | 2015 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 35 |
| CEO | Robert Rauker |
Contact Details
Address: 15 Fetter Lane London, EC4A 1BW United Kingdom | |
| Phone | 888 626 5598 |
| Website | belluscura.com |
Stock Details
| Ticker Symbol | BELL |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | GB00BD3B8Z11 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Robert Rauker | Chief Executive Officer |
| Simon Neicheril | Chief Financial Officer |
| Keith Cook | Chief Operating Officer |